State of Alaska Department of Revenue’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-30,463
| Closed | -$1.01M | – | 1649 |
|
|
2022
Q4 | $1.01M | Buy |
30,463
+175
| +0.6% | +$5.64K | 0.01% | 962 |
|
|
2022
Q3 | $954K | Sell |
30,288
-2,673
| -8% | -$86.6K | 0.01% | 943 |
|
|
2022
Q2 | $1M | Buy |
32,961
+2,670
| +9% | +$72.2K | 0.01% | 965 |
|
|
2022
Q1 | $786K | Sell |
30,291
-405
| -1% | -$9.63K | 0.01% | 1165 |
|
|
2021
Q4 | $626K | Sell |
30,696
-930
| -3% | -$17.8K | 0.01% | 1338 |
|
|
2021
Q3 | $608K | Buy |
31,626
+1,640
| +5% | +$32.7K | 0.01% | 1366 |
|
|
2021
Q2 | $665K | Buy |
29,986
+783
| +3% | +$16.6K | 0.01% | 1305 |
|
|
2021
Q1 | $766K | Sell |
29,203
-4,326
| -13% | -$103K | 0.01% | 1219 |
|
|
2020
Q4 | $626K | Sell |
33,529
-6,580
| -16% | -$123K | 0.01% | 1237 |
|
|
2020
Q3 | $681K | Sell |
40,109
-290
| -0.7% | -$5.64K | 0.01% | 1067 |
|
|
2020
Q2 | $940K | Buy |
40,399
+2,210
| +6% | +$32K | 0.01% | 915 |
|
|
2020
Q1 | $320K | Buy |
38,189
+5,880
| +18% | +$49.5K | 0.01% | 1292 |
|
|
2019
Q4 | $315K | Sell |
32,309
-505
| -2% | -$4.74K | ﹤0.01% | 1474 |
|
|
2019
Q3 | $311K | Buy |
32,814
+18,303
| +126% | +$193K | ﹤0.01% | 1439 |
|
|
2019
Q2 | $172K | Sell |
14,511
-5,484
| -27% | -$66.1K | ﹤0.01% | 1489 |
|
|
2019
Q1 | $351K | Buy |
19,995
+142
| +0.7% | +$2.36K | 0.01% | 1245 |
|
|
2018
Q4 | $344K | Buy |
19,853
+605
| +3% | +$10.3K | 0.01% | 1173 |
|
|
2018
Q3 | $285K | Buy |
19,248
+5,505
| +40% | +$85.4K | ﹤0.01% | 1375 |
|
|
2018
Q2 | $218K | Buy |
13,743
+130
| +1% | +$1.94K | ﹤0.01% | 1464 |
|
|
2018
Q1 | $193K | Buy |
13,613
+5,260
| +63% | +$77.8K | ﹤0.01% | 1427 |
|
|
2017
Q4 | $116K | Hold |
8,353
| – | – | ﹤0.01% | 1478 |
|
|
2017
Q3 | $119K | Buy |
8,353
+80
| +1% | +$1.14K | 0.01% | 1145 |
|
|
2017
Q2 | $130K | Buy |
8,273
+3,613
| +78% | +$52K | 0.01% | 1031 |
|
|
2017
Q1 | $64K | Buy |
4,660
+100
| +2% | +$1.4K | ﹤0.01% | 1067 |
|
|
2016
Q4 | $80K | Buy |
+4,560
| New | +$80.1K | 0.01% | 727 |
|
|
2014
Q1 | – | Sell |
-900
| Closed | -$23K | – | 228 |
|
|
2013
Q4 | $23K | Hold |
900
| – | – | 0.01% | 200 |
|
|
2013
Q3 | $21K | Buy |
+900
| New | +$21K | ﹤0.01% | 198 |
|
Other funds holding VIVO
State of Alaska Department of Revenue's VIVO Position: Q1 2023 in Review
State of Alaska Department of Revenue sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 30,463 shares — an estimated $1.01M sold.
State of Alaska Department of Revenue first reported a position in VIVO in Q3 2013 and held it in 27 quarters. The position peaked at $1.01M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- State of Alaska Department of Revenue reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- State of Alaska Department of Revenue sold 30,463 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.01M.
- State of Alaska Department of Revenue first reported a position in Meridian Bioscience Inc in Q3 2013 and held it in 27 quarters.
- State of Alaska Department of Revenue's Meridian Bioscience Inc position peaked at $1.01M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on State of Alaska Department of Revenue's 13F filing for Q1 2023, filed 17 Apr 2023.